Mepolizumab Cuts Asthma Exacerbations Among High-risk Kids

JAMA. 2022 Sep 27;328(12):1171-1172. doi: 10.1001/jama.2022.16965.
No abstract available

MeSH terms

  • Anti-Asthmatic Agents* / therapeutic use
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Asthma* / drug therapy
  • Asthma* / prevention & control
  • Child
  • Humans
  • Risk
  • Severity of Illness Index
  • Symptom Flare Up*

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • mepolizumab